Pioneering Diagnostics

bioMérieux beer quality

INSPIRING QUALITY INNOVATION IN BIOPRODUCTION AND CELL THERAPY

HOME AGENDA  VENUE & HOTEL INFO


bioXchange 2021 will feature presentations and discussions from leading experts in bioproduction and cell therapy.

"The panel discussion is probably the best part of the conference," said a 2020 attendee. "There are a lot of great questions raised, so I think the volume of feedback is integral to the success of it." 

Review the full agenda below to see what's in store this year, and stay tuned to this page as we announce more.

Register for bioXchange 2021

Fill out the form to register for this year’s workshop.

Day 1 | Tuesday, September 28 | 9:00AM - 5:00PM PST

Keynote Address: Groundbreaking Discoveries that Led to the Future of Bacterial Endotoxin Testing
Dr. Jack Levin, Professor of Laboratory Medicine & Medicine
Univ. of California School of Medicine, San Francisco

rFC Data Review Talk
Ned Mozier, Vice President, Biotherapeutics Pharmaceutical Sciences
Pfizer

Bacterial Endotoxin Testing Panel Discussion
Various Speakers

Leveraging Quality Risk Management for Strategic Planning
Amanda McFarland, QRM Senior Consultant
ValSource, Inc

Commercial Cell Therapy Experience Using Mycoplasma NAT for Product Release: A Five-Year Review
John Duguid, Senior Director, Research and Development
Vericel

Rapid Sterility Testing USP (72,73) Regulatory Update Talk
Tony Cundell
Consultant

Tech Transfer Talk
Kenneth Tai, Senior Manager, Analytical Science and Transfer
Kite Pharma


Day 2 | Wednesday, September 29 | 8:30AM - 12:30PM PST

All(o) Things Considered: The Pleasure and Pain of Making More
Brent Rice, Director, Manufacturing Science & Technology
Precision BioSciences

QC Release Testing for Gene/Cell Therapy Products: Today and Tomorrow's View
Audrey Chang, PhD, VP of QC and Analytical Services
Vigene BioSciences


Questions? We've Got You Covered.

Reach out to Derek Jacobs at derek.jacobs@biomerieux.com with any questions about this year's event. Be sure to bookmark this page and join our LinkedIn group to receive the latest updates. We are currently working on finalizing our agenda and hope to share more information soon.